VITROS Immunodiagnostic Products Anti-SARS-CoV-2 Total Reagent Pack, VITROS Immunodiagnostic Products Anti-SARS-CoV-2 Total Calibrators
by Ortho-Clinical Diagnostics, Inc.
De Novo DEN210040
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA De NovoDENG | NumberDEN210040 | Date5 May 2023 | StatusActive |
Recalls
No FDA recalls found in the data synced 23 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA De Novo Active
Specification
- De Novo Number
- FDA Product Code
- QVP
- Device Class
- Class II
- Regulation
- 21 CFR Part 866.3983
- Advisory Committee
- Microbiology
- FDA Decision
- DENG De Novo granted
Overview
AI-generated summary, 19 Sep 2026
This device is a chemiluminescent immunoassay for the qualitative detection of total antibodies to SARS-CoV-2. It is classified as a SARS-CoV-2 serology test under the device nomenclature for microbiology diagnostics, designed to identify antibodies in human serum and plasma samples collected via K₂-EDTA, K₃-EDTA, or lithium heparin.
The VITROS Immunodiagnostic Products Anti-SARS-CoV-2 Total Reagent Pack and Calibrators are intended for use exclusively on the VITROS ECi/ECiQ/3600 Immunodiagnostic System or the VITROS 5600/XT 7600 Integrated Systems. Supplied as single-use components, the device requires no sterilisation beyond manufacturer-provided packaging. Regulated under FDA 510(k) clearance (K210040), it is distributed for in vitro diagnostic use in clinical microbiology settings.